The Superintendent of Public Health has said in a statement this morning “that following consultation with the Competent Authority for medical devices and a further evaluation of the evidence available to date by local experts, it has been concluded that to date there is no scientific evidence to link PIP breast implants with an increased incidence of breast cancer but there may be some evidence to relate these implants with a slightly higher rupture rate when compared to other types of implants. The position and recommendations made by other European health authorities were also reviewed and evaluated.”

“On the basis of the above appraisals,” the Superintendent of Public Health continued, that it “would like to reassure women that there is no indication for women who have this type of breast implant to have their implants removed or replaced. In view of the possibility of an increased incidence of leakage from these implants, the Superintendent recommends that these women are to be followed up, preferably by an ultrasound scan, to ensure that there is no leakage of the implant. The frequency of the follow up and further management is to be determined by the surgeon on an individual patient basis.”

“To date it has been ascertained that around 80 women have received such implants, the majority of them within the private sector.”

The superintendence said it will continue to monitor developments in the area and will advise the general public should there be any further action that will need to be taken.

Permalink: ‘No indication for women to remove their PIP breast implants’